Low-dose IL-2 may enhance the effect of vedolizumab. Lee CH, Huang S, Hsu P, Leong RW, et al. Scand J Gastroenterol 2022;57:1404-1405.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lee CH, Huang S, Hsu P, Leong RW, et al. Low-dose IL-2 may enhance the effect of vedolizumab. Scand J Gastroenterol 2022;57:1404-1405.
PMID: 35701147